Evidence map›Paper›PMID 32015380›Full record

ArticleScientific reports2020

Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study.

Raluca Cosgarea, Robert Pollmann, Jusra Sharif, Thomas Schmidt, Ronja Stein, Aura Bodea, Thorsten Auschill, Anton Sculean, Rüdiger Eming, Brandon Greene and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Different Approaches to Oral Lichen Planus Treatment: A Narrative Review.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Treatments in oral lichen planus: a review.Frontiers in oral health · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Lichen Planus: What is New in Diagnosis and Treatment?American journal of clinical dermatology · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. What can we learn from treatments of oral lichen planus?Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Raluca Cosgarea *Department of Periodontology, Philipps-University Marburg, Marburg, Germany. ralucacosgarea@gmail.com.
Robert Pollmann *Department of Dermatology und Allergology, Philipps-University Marburg, Marburg, Germany.
Jusra SharifDepartment of Periodontology, Philipps-University Marburg, Marburg, Germany.
Thomas SchmidtDepartment of Dermatology und Allergology, Philipps-University Marburg, Marburg, Germany.
Ronja SteinDepartment of Dermatology und Allergology, Philipps-University Marburg, Marburg, Germany.
Aura BodeaPeriodontal Private Practice, Cluj-Napoca, Romania.
Thorsten AuschillDepartment of Periodontology, Philipps-University Marburg, Marburg, Germany.
Anton SculeanDepartment of Periodontology, University of Bern, Dental School, Bern, Switzerland.
Rüdiger EmingDepartment of Dermatology und Allergology, Philipps-University Marburg, Marburg, Germany.
Brandon GreeneInstitute of Biometry and Statistics, Philipps-University Marburg, Marburg, Germany.
Michael HertlDepartment of Dermatology und Allergology, Philipps-University Marburg, Marburg, Germany.
Nicole ArweilerDepartment of Periodontology, Philipps-University Marburg, Marburg, Germany.
Philipps University of Marburg · DEUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects. The aim of this study was to determine the clinical and immunological efficacy of photodynamic therapy (PDT) in OLP as an alternative, easy-to-use, safe and non-invasive treatment. Twenty patients with OLP were treated with PDT in a prospective case-controlled pilot-study. PDT was performed on the most extensive oral lesion in 4 sessions (day 1, 3, 7, 14). Peripheral blood and lesional T cells were analysed before (day 1) and after PDT treatment (day 28). PDT led to a statistically significant reduction of clinical parameters (lesion size, ABSIS, Thongprasom-score) and improvement of all evaluated quality-of-life (QOL) items. The clinical improvement was accompanied by a significant decrease of the relative number of CD4+ and CD8+ T cells in mucosal OLP-lesions. Furthermore, CXCL10 plasma levels were decreased and the number of activated peripheral CD4 + CD137+ and CD8 + CD137+ T cells and IL-17-secreting T cells was diminished. PDT treatment in OLP leads to lesion reduction and improvement of QOL, and induces local and systemic anti-inflammatory effects. The study identifies PDT as a novel therapeutic option in OLP.

Indexed as

PhotochemotherapyCase-Control StudiesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChronic DiseaseFemaleHumansImmunologic FactorsLichen Planus, OralMaleMiddle AgedPhotosensitizing AgentsPilot ProjectsProspective StudiesQuality of LifeImmunologic FactorsPhotosensitizing Agents

Identifiers

PMID32015380
PMCPMC6997407
OpenAlexW3003500584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.